Story
China Probes DeepSeek, Moonshot AI Over Alleged Data Routing to US Models
Summary
China's internet regulator is investigating AI firms DeepSeek and Moonshot AI following allegations that they, along with other major tech companies, routed sensitive user data to U.S.-based models without authorization.
China’s top internet regulator is investigating domestic AI firms DeepSeek and Moonshot AI, according to a report from The Information citing people familiar with the matter. The probe follows allegations that the companies improperly routed sensitive user data to AI models developed by U.S.-based Anthropic.
Scrutiny Follows Anthropic Report
The investigation was reportedly triggered by a 154-page report published by Anthropic on September 10. The U.S. AI firm detailed how seven Chinese companies were allegedly using its Claude models on a large scale without authorization.
Following the report's release, the Cyberspace Administration of China (CAC) summoned representatives from all seven named companies for questioning. This marked the first instance of a U.S. AI company providing detailed evidence to support such claims, escalating concerns over data security and unauthorized technology use.
Details of the Allegations
The Anthropic report contained specific and serious allegations, including that sensitive Chinese state, police, and military data was being routed to U.S. models. One key claim was that DeepSeek forwarded requests from engineers working on a police surveillance system to a Claude model.
AdIn addition to DeepSeek and Moonshot AI, the other five companies identified in the report were:
- Alibaba
- Zhipu
- SenseTime
- MiniMax
- Xiaomi
Implications for the AI Sector
This regulatory probe highlights the significant geopolitical tensions and national security concerns surrounding the global AI industry. For the Chinese companies involved, an official investigation could result in significant penalties and reputational damage, potentially impacting their access to both domestic and international markets.
The situation underscores China's increasing focus on data sovereignty and its efforts to control the flow of information to foreign entities. For investors, this development signals heightened regulatory risk for China's rapidly growing AI sector, particularly for firms that may be relying on unauthorized access to foreign foundational models.
Read next
More on Stocks
AI Infrastructure Firm Accelevation Sets IPO Terms, Targeting Up to $5.4 Billion Valuation
AI infrastructure provider Accelevation is targeting a valuation of up to $5.37 billion and aims to raise as much as $720 million in its upcoming U.S. initial public offering, capitalizing on strong investor interest in artificial intelligence.
Quest, Labcorp Shares Tumble on Proposed Medicare Reimbursement Cuts
Shares of Quest Diagnostics and Labcorp fell sharply in premarket trading after the Centers for Medicare & Medicaid Services proposed significant cuts to laboratory testing fees, set to begin in 2027.
Roche's Obesity Drug Enicepatide Shows 15.5% Weight Loss in Mid-Stage Diabetes Trial
Swiss drugmaker Roche announced its experimental obesity drug, enicepatide, helped patients with type 2 diabetes achieve an average 15.5% weight loss and significant blood sugar control in a mid-stage study.
DoorDash to Pay $131.5 Million in NYC Settlement Over Worker Pay Issues
Food delivery giant DoorDash has agreed to a $131.5 million settlement with New York City following a probe that found the company underpaid or delayed payments to its delivery workers.